12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several health care stocks showed significant movement. FibroBiologics, Sonnet BioTherapeutics, GlucoTrack, Clene, Larimar Therapeutics, and BiomX were among the gainers, with FibroBiologics leading with a 25% increase. On the downside, QuidelOrtho, Alzamend Neuro, Assure Hldgs, Adial Pharmaceuticals, NeuroOne Medical Tech, and NanoString Technologies experienced declines, with QuidelOrtho dropping 28.2% after its Q4 earnings release.
February 13, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
FibroBiologics saw a significant increase of 25% to $17.43 in Tuesday's after-market session.
The substantial increase in FibroBiologics' stock price indicates strong investor confidence, potentially due to positive developments or expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
QuidelOrtho's stock declined by 28.2% to $47.9 following the release of its Q4 earnings.
The significant drop in QuidelOrtho's stock price post-Q4 earnings suggests the results did not meet market expectations, leading to negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95